VNA 和 PACS 市场：依产品类型、依模式、依部署类型、依应用、依最终用户、依地区、机会、预测，2017-2031年

全球 VNA 和 PACS 市场规模预计将从2023年的38.7亿美元成长到2031年的70亿美元，2024-2031年的年复合成长率为 7.68%。 PACS 和 VNA 等医学影像管理解决方案用于同时比较患者或一组患者在不同时间范围内拍摄的影像，以确定疾病进展和预后。使用这些技术，所有医学影像檔案都可以数位化组织和储存，而不是实体檔案。这些解决方案还允许将医学影像中的病患资料与其他来源的资讯结合，例如电子病历、放射资讯系统（RIS）和医疗资讯系统。

医疗影像处理技术的投资增加、影像处理设备的需求增加、影像诊断模式的技术发展、人口老化增加影像处理量、医疗IT和EHR的扩大引进、医疗保健巨量资料的成长市场是由不断增加的存在所驱动的此外，PACS/VNA 和电子病历（EMR）的整合、人工智慧（AI）的引进、混合和基于云端的医学成像系统的普及以及快速扩展的医疗成像领域推动了医学成像市场的发展。有很大的成长空间。

本报告调查了全球 VNA 和 PACS 市场，提供市场概述，依产品类型、模式、部署类型、应用程式、最终用户、地区趋势和进入市场的公司概况。

目录

第1章 研究方法

第2章 专案范围与定义

第3章 执行摘要

第4章 2017-2031年全球 VNA 与 PACS 市场展望

• 市场规模与预测
• 市场占有率和预测
• 2023年市场地图分析
  • 依产品类型
  • 依方式
  • 依部署类型
  • 依用途
  • 依最终用户
  • 依地区

第5章 北美 VNA 与 PACS 市场展望，2017-2031年

第6章 欧洲 VNA 与 PACS 市场展望，2017-2031

第7章 亚太地区 VNA 与 PACS 市场展望，2017-2031年

第8章 南美洲 VNA 与 PACS 市场展望，2017-2031

第9章 中东与非洲 VNA 与 PACS 市场展望，2017-2031年

第10章 供需分析

第11章 进出口分析

第12章 价值链分析

第13章 波特五力分析

第14章 PESTLE分析

第15章 价格分析

第16章 市场动态

第17章 市场趋势与发展

第18章 监理架构与创新

第19章 专利状况

第20章 个案研究

第21章 竞争态势

• 前5名市场领导者的竞争矩阵
• 前5名进入公司的SWOT 分析
• 市场前10位主要参与者的情况
  • Koninklijke Philips N.V.
  • FUJIFILM Holdings America Corporation
  • GE HealthCare Technologies Inc.
  • Siemens Healthcare Private Limited
  • ScImage, Inc.
  • Sectra AB
  • RamSoft, Inc.
  • Avicenna.AI
  • Canon Medical Systems Corporation
  • Hyland Software, Inc.

第22章 策略建议

第23章 查询及免责声明

Global VNA and PACS market is projected to witness a CAGR of 7.68% during the forecast period 2024-2031, growing from USD 3.87 billion in 2023 to USD 7.00 billion in 2031. Medical imaging management solutions such as Picture Archiving and Communication System (PACS) and Vendor Neutral Archive (VNA) are used to compare images of a patient or group of patients simultaneously that are taken at different time frames to gauge the disease's progression and prognosis. With the help of these technologies, physical archiving is replaced by digitally organizing and storing all medical imaging files. These solutions also make it possible to combine patient data from medical images with information from other sources, including electronic health records, radiology information systems (RIS), and health information systems. Increasing investments in medical imaging technologies, increased demand for imaging equipment, technological developments in diagnostic imaging modalities, an aging population that drives up imaging volumes, growing healthcare IT & EHR adoption, and the growth of big data presence in healthcare are some of the reasons driving this market's growth. Furthermore, there should be a lot of room for growth in the medical imaging market due to the integration of PACS/VNA with Electronic Medical Record (EMR), the introduction of artificial intelligence (AI), the growing popularity of hybrid and cloud-based medical imaging systems, and the quickly expanding telehealth sector.

For example, a vendor-neutral platform solution for echocardiography image processing and reporting, called Ultrasound Workspace, was introduced by Koninklijke Philips N.V. in March 2022 at the American College of Cardiology's Annual Scientific Session & Expo (ACC2022). It is a sophisticated vendor-neutral system for analyzing and reporting 2D and 3D echocardiograms. However, the extended product lifecycle of VNA and financial limitations limit the market's expansion. Additionally, the market's expansion is estimated to be fueled by improved data transfer and enhanced interoperability. For instance, a leading supplier of diagnostic and enterprise imaging solutions, FUJIFILM Holdings America Corporation, stated in February 2024 that their Synapse VNA and Synapse Radiology PACS were awarded the best in class at 2024 Best in KLAS Awards: Software and Services.

Surge in Digitalization of Medical Imaging Leading to Market Expansion

The way medical images are obtained, stored, and disseminated has undergone a radical change because of the digitalization of medical imaging. Along with improving patient care, this change has been a major factor in the market's drastic rise for PACS and VNA worldwide. Medical images were previously recorded on X-ray films and kept in physical archives, which came with a number of difficulties. The medical imaging industry has gone digital, meaning that film is no longer necessary. This allows medical professionals to take, store, and distribute images in electronic formats. This change has not only enhanced the quality of the images but has also simplified the management and retrieval of patient data. Electronic technologies simplify saving, retrieving, and managing digital photos. Centralized digital repositories for medical images are made available to healthcare facilities via PACS solutions, and VNAs expand this capacity to accommodate other patient data types. Effective data management improves patient care by streamlining processes and cutting down on administrative burdens. Digitalization facilitates the interoperability between various medical imaging systems and devices. PACS and VNA systems are made to work easily with diverse imaging devices made by different companies. Regardless of the source, this interoperability guarantees that medical pictures can be accessed and shared throughout the healthcare ecosystem. Healthcare practitioners can review patient data remotely from any location with an internet connection by using digital medical imaging. With telemedicine and remote consultations, where experts may give their input without being physically present, the market promises to expand further.

For example, Avicenna.AI, a medical imaging firm, in February 2023 introduced CINA-iPE, an AI tool that is CE certified and checks CT scan images of the chest for the possibility of an inadvertent pulmonary embolism. The first product in Avicenna.AI's new CINA Incidental line of medical imaging products is CINA-iPE.AI, which uses CT images to identify unknown disorders.

Growth in Market Due to Interoperability and Integration

It is now essential to have seamless access to patient data and medical imaging in the ever-changing healthcare ecosystem. The market for PACS and VNAs, which is growing significantly because of interoperability and integration, was created in response to this demand. The capacity of various systems, gadgets, and applications to easily connect and exchange data is referred to as interoperability in the healthcare industry. Regardless of the vendor or data format, interoperability in the context of VNA and PACS enables diverse healthcare systems to collaborate effectively. This is important since most imaging equipment used by healthcare organizations is multi-vendor, which means it comes from various manufacturers. These gaps are filled by interoperable PACS and VNAS, which promote effective data interchange.

While interoperability guarantees compatibility between systems, integration guarantees seamless system integration. By offering a uniform platform for viewing and managing patient data, PACS and VNA solutions that are linked with an organization's current systems, such as Radiology Information Systems (RIS) and Electronic Health Records (EHRS), expedite operations. This integration lessens the administrative load and improves operational efficiency. Data redundancy is decreased via integrated and interoperable VNA and PACS systems. These systems operate for centralized storage as an alternative to storing the same patient data or photographs in several places. This reduces the possibility of data inaccuracies and inconsistencies, which can be crucial when making decisions in the healthcare sector. It also saves storage space. Systems that are compatible, guarantee that patient data is accessible when and where it is needed. This facilitates faster access to vital medical pictures and patient histories for radiologists and physicians. In the end, timely access to thorough patient data improves patient care by facilitating quicker and more accurate diagnosis and treatment decisions. Interoperability and integration go hand in hand to facilitate better healthcare IT.

For instance, RamSoft, Inc. (Canada) introduced its imaging EMR solution, OmegaAl, in January 2024. VNA, Enterprise Imaging, PACS, RIS, streamlined image exchange/sharing, routing, and storage, a zero-footprint (ZFP) viewer, unified worklist, radiology reporting, document management, peer, patient portal, and a real-time business intelligence and analytics solution are all combined into one cloud-native, serverless imaging EMR software platform.

Increasing Dominance of On-Site (Premise) Segment Leads to Market Growth

The conventional approach of software implementation is the on-site model. For storing and managing patient data, hospitals and healthcare facilities often prefer on-premises data storage. When customers need to update their systems or switch to new technology, they use the on-site mode of delivery. Some end users or service providers choose the on-site mode of delivery since they are unfamiliar with VNA and PACS technology. Because on-premises software is becoming widely popular among service providers worldwide, it is anticipated to hold a sizable revenue share in the market under study. The on-premises delivery model offers additional protection because servers and data are physically housed in service providers' offices, allowing specialised integration with other current company systems. For example, in May 2022, Cleo Communications LLC-a cloud-based integration platform-published an article stating that on-premises software is not hosted on a vendor-supplied cloud but rather is installed and maintained internally at a physical office. The companies themselves manage these, but the systems and data are still under their control. Therefore, it is anticipated that the security associated with the mode of delivery will propel the market's segment growth. Furthermore, the segment is growing rapidly due to innovation, new product launches, and ongoing efforts by significant players. For example, ScImage, Inc., a top supplier of cloud-based enterprise imaging and reporting solutions, introduced its PICOM365 enterprise imaging process in February 2022. This PICOM365 is powered by Microsoft Azure Cloud and offers all the features of on-premises PACS software systems. Therefore, owing to the above-mentioned factors, the segment is expected to grow over the forecast period.

North America to Dominate the VNA and PACS Market

The market for Vendor-Neutral Archive (VNA) and PACS in North America is anticipated to grow profitably due to the rising desire for PAC systems to be universal, the decline in data storage prices, and the compatibility of VNA with data archive systems. In addition to these, the healthcare IT industry's well-developed infrastructure, the existence of significant companies, and the measures implemented by market participants in regions like the United States are supporting the market's expansion. Furthermore, it is anticipated that the researched markets in Canada and Mexico will expand during the period. The market is expected to increase because of product launches and collaborations between national service providers and market participants.

For example, a Mexican platform called Eva, LLC expanded digital diagnostics throughout Latin America in January 2022, allowing remote test analysis and extending healthcare access outside of major cities. This platform offers affordable, digital substitutes for traditional imaging plates, expediting the diagnostic procedure. Enlarging and rotating images facilitates improved interpretation and analysis. Its services, which digitise the diagnostic procedure, are far less expensive than physical imaging plates. Additionally, Sectra AB and North York General Hospital (NYGH) in Canada signed a contract in April 2022. NYGH would examine and archive images using Sectra's enterprise imaging solution's radiology and breast imaging modules as well as VNA. By doing more without adding to the stress on staff, NYGH will be able to improve patient care by boosting the efficiency of radiological reading and streamlining present procedures. Therefore, market expansion in North America is anticipated to be driven by the advancements in each of the region's member states.

Future Market Scenario (2024-2031F)

Main factors contributing to the anticipated growth of VNA and PACS market are the rising geriatric population and the increasing instances of chronic diseases that lead to increased volumes of diagnostic imaging. However, growing big data presence in healthcare, and growing healthcare IT & EHR adoption are also going to fuel the market growth in future. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an un-paralleled rate, introducing cost-effective and efficient technologies. Government policies and policies made by welfare bodies are also greatly fueling the market expansion.

For instance, in April 2022, to standardise the digital imaging networks' picture archiving and communication systems (DIN-PACS) for ten years at US Navy and Air Force medical treatment facilities, the US Department of Defence (DoD) and Fujifilm Holdings America Corporation worked together on the Synapse PACS solutions.

Key Players Landscape and Outlook

Major players operating in the market are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launch of newly developed VNA and PACS solutions to help researchers and strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For instance, to improve imaging operations, InsiteOne (US) announced in November 2023 that it would purchase BRIT Systems, Inc.'s cloud-native RIS/PACS/VNA system. The goal of this acquisition would be to create low-cost solutions that raise operational efficiency and improve patient care.

Similarly, to provide digital pathology departmental solutions that give healthcare providers a thorough understanding of patient records, GE HealthCare Technologies Inc. (US) and Tribun Health (Paris) partnered in November 2022. The goal of this collaboration was to integrate Tribun's Health Suite data with GE Healthcare Technologies Inc.'s solutions, including its vendor-neutral archive (VNA) solution portfolio.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global VNA and PACS Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. VNA
    • 4.2.1.2. PACS
  • 4.2.2. By Modality
    • 4.2.2.1. CT scans
    • 4.2.2.2. MRI scans
    • 4.2.2.3. Ultrasounds
    • 4.2.2.4. X-rays
    • 4.2.2.5. Others
  • 4.2.3. By Deployment Type
    • 4.2.3.1. On-Site Model
    • 4.2.3.2. Cloud-Based Model
    • 4.2.3.3. Hybrid Model
  • 4.2.4. By Application
    • 4.2.4.1. Cardiology
    • 4.2.4.2. Oncology
    • 4.2.4.3. Radiology
    • 4.2.4.4. Neurology
    • 4.2.4.5. Pathology
    • 4.2.4.6. Others
  • 4.2.5. By End-user
    • 4.2.5.1. Hospitals and Clinics
    • 4.2.5.2. Diagnostic Centres
    • 4.2.5.3. Ambulatory Surgical Centres
    • 4.2.5.4. Others
  • 4.2.6. By Region
    • 4.2.6.1. North America
    • 4.2.6.2. Europe
    • 4.2.6.3. Asia-Pacific
    • 4.2.6.4. South America
    • 4.2.6.5. Middle East and Africa
  • 4.2.7. By Company Market Share (%), 2023
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Product Type
  • 4.3.2. By Modality
  • 4.3.3. By Deployment Type
  • 4.3.4. By Application
  • 4.3.5. By End-user
  • 4.3.6. By Region

5. North America VNA and PACS Market Outlook, 2017-2031F*

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type
    • 5.2.1.1. VNA
    • 5.2.1.2. PACS
  • 5.2.2. By Modality
    • 5.2.2.1. CT scans
    • 5.2.2.2. MRI scans
    • 5.2.2.3. Ultrasounds
    • 5.2.2.4. X-rays
    • 5.2.2.5. Others
  • 5.2.3. By Deployment Type
    • 5.2.3.1. On-Site Model
    • 5.2.3.2. Cloud-Based Model
    • 5.2.3.3. Hybrid Model
  • 5.2.4. By Application
    • 5.2.4.1. Cardiology
    • 5.2.4.2. Oncology
    • 5.2.4.3. Radiology
    • 5.2.4.4. Neurology
    • 5.2.4.5. Pathology
    • 5.2.4.6. Others
  • 5.2.5. By End-user
    • 5.2.5.1. Hospitals and Clinics
    • 5.2.5.2. Diagnostic Centres
    • 5.2.5.3. Ambulatory Surgical Centres
    • 5.2.5.4. Others
  • 5.2.6. By Country Share
    • 5.2.6.1. United States
    • 5.2.6.2. Canada
    • 5.2.6.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States VNA and PACS Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product Type
        • 5.3.1.2.1.1. VNA
        • 5.3.1.2.1.2. PACS
      • 5.3.1.2.2. By Modality
        • 5.3.1.2.2.1. CT scans
        • 5.3.1.2.2.2. MRI scans
        • 5.3.1.2.2.3. Ultrasounds
        • 5.3.1.2.2.4. X-rays
        • 5.3.1.2.2.5. Others
      • 5.3.1.2.3. By Deployment Type
        • 5.3.1.2.3.1. On-Site Model
        • 5.3.1.2.3.2. Cloud-Based Model
        • 5.3.1.2.3.3. Hybrid Model
      • 5.3.1.2.4. By Application
        • 5.3.1.2.4.1. Cardiology
        • 5.3.1.2.4.2. Oncology
        • 5.3.1.2.4.3. Radiology
        • 5.3.1.2.4.4. Neurology
        • 5.3.1.2.4.5. Pathology
        • 5.3.1.2.4.6. Others
      • 5.3.1.2.5. By End-user
        • 5.3.1.2.5.1. Hospitals and Clinics
        • 5.3.1.2.5.2. Diagnostic Centres
        • 5.3.1.2.5.3. Ambulatory Surgical Centres
        • 5.3.1.2.5.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe VNA and PACS Market Outlook, 2017-2031F

• 6.1.1. Germany
• 6.1.2. France
• 6.1.3. Italy
• 6.1.4. United Kingdom
• 6.1.5. Russia
• 6.1.6. Netherlands
• 6.1.7. Spain
• 6.1.8. Turkey
• 6.1.9. Poland

7. Asia-Pacific VNA and PACS Market Outlook, 2017-2031F

• 7.1.1. India
• 7.1.2. China
• 7.1.3. Japan
• 7.1.4. Australia
• 7.1.5. Vietnam
• 7.1.6. South Korea
• 7.1.7. Indonesia
• 7.1.8. Philippines

8. South America VNA and PACS Market Outlook, 2017-2031F

• 8.1.1. Brazil
• 8.1.2. Argentina

9. Middle East and Africa VNA and PACS Market Outlook, 2017-2031F

• 9.1.1. Saudi Arabia
• 9.1.2. UAE
• 9.1.3. South Africa

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

• 18.1. Clinical Trials
• 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

• 21.1. Competition Matrix of Top 5 Market Leaders
• 21.2. SWOT Analysis for Top 5 Players
• 21.3. Key Players Landscape for Top 10 Market Players
  • 21.3.1. Koninklijke Philips N.V.
    • 21.3.1.1. Company Details
    • 21.3.1.2. Key Management Personnel
    • 21.3.1.3. Products and Services
    • 21.3.1.4. Financials (As Reported)
    • 21.3.1.5. Key Market Focus and Geographical Presence
    • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 21.3.2. FUJIFILM Holdings America Corporation
  • 21.3.3. GE HealthCare Technologies Inc.
  • 21.3.4. Siemens Healthcare Private Limited
  • 21.3.5. ScImage, Inc.
  • 21.3.6. Sectra AB
  • 21.3.7. RamSoft, Inc.
  • 21.3.8. Avicenna.AI
  • 21.3.9. Canon Medical Systems Corporation
  • 21.3.10. Hyland Software, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 3. Global VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 4. Global VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 5. Global VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 6. Global VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 7. Global VNA and PACS Market Share (%), By Region, 2017-2031F
• Figure 8. North America VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 9. North America VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 10. North America VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 11. North America VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 12. North America VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 13. North America VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 14. North America VNA and PACS Market Share (%), By Country, 2017-2031F
• Figure 15. United States VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 16. United States VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 17. United States VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 18. United States VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 19. United States VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 20. United States VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 21. Canada VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 22. Canada VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 23. Canada VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 24. Canada VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 25. Canada VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 26. Canada VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 27. Mexico VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 28. Mexico VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 29. Mexico VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 30. Mexico VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 31. Mexico VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 32. Mexico VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 34. Europe VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 35. Europe VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 36. Europe VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 37. Europe VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 38. Europe VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 39. Europe VNA and PACS Market Share (%), By Country, 2017-2031F
• Figure 40. Germany VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 41. Germany VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 42. Germany VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 43. Germany VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 44. Germany VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 45. Germany VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 46. France VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 47. France VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 48. France VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 49. France VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 50. France VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 51. France VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 52. Italy VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 53. Italy VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 54. Italy VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 55. Italy VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 56. Italy VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 57. Italy VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 58. United Kingdom VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 59. United Kingdom VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 60. United Kingdom VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 61. United Kingdom VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 62. United Kingdom VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 63. United Kingdom VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 64. Russia VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 65. Russia VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 66. Russia VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 67. Russia VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 68. Russia VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 69. Russia VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 70. Netherlands VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 71. Netherlands VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 72. Netherlands VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 73. Netherlands VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 74. Netherlands VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 75. Netherlands VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 76. Spain VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 77. Spain VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 78. Spain VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 79. Spain VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 80. Spain VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 81. Spain VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 82. Turkey VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 83. Turkey VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 84. Turkey VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 85. Turkey VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 86. Turkey VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 87. Turkey VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 88. Poland VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 89. Poland VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 90. Poland VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 91. Poland VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 92. Poland VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 93. Poland VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 94. South America VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 95. South America VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 96. South America VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 97. South America VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 98. South America VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 99. South America VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 100. South America VNA and PACS Market Share (%), By Country, 2017-2031F
• Figure 101. Brazil VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 102. Brazil VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 103. Brazil VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 104. Brazil VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 105. Brazil VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 106. Brazil VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 107. Argentina VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 108. Argentina VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 109. Argentina VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 110. Argentina VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 111. Argentina VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 112. Argentina VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 113. Asia-Pacific VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 114. Asia-Pacific VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 115. Asia-Pacific VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 116. Asia-Pacific VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 117. Asia-Pacific VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 118. Asia-Pacific VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 119. Asia-Pacific VNA and PACS Market Share (%), By Country, 2017-2031F
• Figure 120. India VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 121. India VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 122. India VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 123. India VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 124. India VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 125. India VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 126. China VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 127. China VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 128. China VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 129. China VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 130. China VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 131. China VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 132. Japan VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 133. Japan VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 134. Japan VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 135. Japan VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 136. Japan VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 137. Japan VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 138. Australia VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 139. Australia VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 140. Australia VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 141. Australia VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 142. Australia VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 143. Australia VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 144. Vietnam VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 145. Vietnam VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 146. Vietnam VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 147. Vietnam VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 148. Vietnam VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 149. Vietnam VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 150. South Korea VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 151. South Korea VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 152. South Korea VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 153. South Korea VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 154. South Korea VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 155. South Korea VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 156. Indonesia VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 157. Indonesia VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 158. Indonesia VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 159. Indonesia VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 160. Indonesia VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 161. Indonesia VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 162. Philippines VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 163. Philippines VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 164. Philippines VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 165. Philippines VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 166. Philippines VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 167. Philippines VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 168. Middle East & Africa VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 169. Middle East & Africa VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 170. Middle East & Africa VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 171. Middle East & Africa VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 172. Middle East & Africa VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 173. Middle East & Africa VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 174. Middle East & Africa VNA and PACS Market Share (%), By Country, 2017-2031F
• Figure 175. Saudi Arabia VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 176. Saudi Arabia VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 177. Saudi Arabia VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 178. Saudi Arabia VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 179. Saudi Arabia VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 180. Saudi Arabia VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 181. UAE VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 182. UAE VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 183. UAE VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 184. UAE VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 185. UAE VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 186. UAE VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 187. South Africa VNA and PACS Market, By Value, In USD Billion, 2017-2031F
• Figure 188. South Africa VNA and PACS Market Share (%), By Product Type, 2017-2031F
• Figure 189. South Africa VNA and PACS Market Share (%), By Modality, 2017-2031F
• Figure 190. South Africa VNA and PACS Market Share (%), By Deployment Type, 2017-2031F
• Figure 191. South Africa VNA and PACS Market Share (%), By Application, 2017-2031F
• Figure 192. South Africa VNA and PACS Market Share (%), By End-user, 2017-2031F
• Figure 193. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 194. By Modality Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 195. By Deployment Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 196. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 197. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 198. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023